Maricel Gómez-Soler
Affiliations: | 2012-2016 | Department of Pathology and Experimental Therapeutics | Universitat de Barcelona, Barcelona, Cataluña, Spain |
Google:
"Maricel Gómez-Soler"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Fernández-Dueñas V, Gómez-Soler M, Valle-León M, et al. (2019) Revealing Adenosine A-Dopamine D Receptor Heteromers in Parkinson's Disease Post-Mortem Brain through a New AlphaScreen-Based Assay. International Journal of Molecular Sciences. 20 |
Gómez-Soler M, Cordobilla B, Morató X, et al. (2018) Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism. Frontiers in Neuroscience. 12: 604 |
Sahlholm K, Gómez-Soler M, Valle-León M, et al. (2017) Antipsychotic-Like Efficacy of Dopamine D2 Receptor-Biased Ligands is Dependent on Adenosine A2A Receptor Expression. Molecular Neurobiology |
Guixà-González R, Javanainen M, Gómez-Soler M, et al. (2016) Membrane omega-3 fatty acids modulate the oligomerisation kinetics of adenosine A2A and dopamine D2 receptors. Scientific Reports. 6: 19839 |
Constantino LC, Pamplona FA, Matheus FC, et al. (2015) Adenosine A1 receptor activation modulates N-methyl-d-aspartate (NMDA) preconditioning phenotype in the brain. Behavioural Brain Research. 282: 103-10 |
Fernández-Dueñas V, Taura JJ, Cottet M, et al. (2015) Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in rats. Disease Models & Mechanisms. 8: 57-63 |
Fernández-Dueñas V, Gómez-Soler M, López-Cano M, et al. (2014) Uncovering caffeine's adenosine A2A receptor inverse agonism in experimental parkinsonism. Acs Chemical Biology. 9: 2496-501 |
Ciruela F, Vallano A, Cuffí ML, et al. (2014) Deciphering G protein-coupled receptor biology with fluorescence-based methods. Current Pharmaceutical Biotechnology. 15: 962-70 |